-
Mashup Score: 8
A combination of two existing skin cancer drugs and a third experimental drug could lead to a new strategy for treating patients who do not respond to existing therapies, a new study in mice suggests.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Karen, 59, was told she only had months to live when she was diagnosed with bowel cancer seven years ago. Now, she lives ‘near normal life’ on a combination of chemotherapy and the targeted drug cetuximab. Here she tells her story.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
"Seven years ago, I was told I had just months to live." - Karen, diagnosed with #BowelCancer in 2015. In support of our appeal, Karen shares how #CombinationTherapies are helping her to live well with cancer: https://t.co/Zs7LH48Q7i #UnlockTreatments #LetsFinishCancer https://t.co/4xwSE9vopr
-
-
Mashup Score: 6
We are looking for new combination treatments to outsmart cancer and prevent drug resistance. Help us find better cancer treatment options by donating today.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Today, we're launching our appeal to find new ways to outsmart #Cancer by using treatments in combination. Please support our research to unlock new #CombinationTherapies, so more people will survive cancer: https://t.co/As7ftn3zH9 #UnlockTreatments #LetsFinishCancer https://t.co/G3ErXFhcwW
-
-
Mashup Score: 5
In this edition of Research Arc, we explore therapeutic combinations.
Source: info.cell.comCategories: General Medicine News, Latest HeadlinesTweet-
In this Research Arc collection, we present recent studies that underscore the potential of #CombinationTherapies for the treatment of various diseases. https://t.co/FxFYXHH1m3 https://t.co/yyeOSEeWYd
-
-
Mashup Score: 7Combination Therapies - 2 year(s) ago
Overview The National Cancer Instituteās Division of Cancer Biology (NCI DCB) and IBM Research are partnering to build a Community of Accelerated Discovery composed of a multi-disciplinary group of researchers focused on the discovery implications of clinical translation of biologically informed…
Source: apply.hub.kiCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
If you are a cancer researcher, engineer, or computational scientist, apply by the end of TODAY to attend the @NCICancerBio & @IBMResearch #ComboTherapies4Cancer Ideas Lab for the development of biologically informed models of #CombinationTherapies: https://t.co/R5PjoYbTko https://t.co/zbbrW30P18
-
-
Mashup Score: 12Combination Therapies - 2 year(s) ago
Overview The National Cancer Instituteās Division of Cancer Biology (NCI DCB) and IBM Research are partnering to build a Community of Accelerated Discovery composed of a multi-disciplinary group of researchers focused on the discovery implications of clinical translation of biologically informed…
Source: apply.hub.kiCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Cancer researchers, #engineers, computational scientists, and more can apply to attend the @NCICancerBio & @IBMResearch #ComboTherapies4Cancer Ideas Lab for the development of biologically-informed models of #CombinationTherapies: https://t.co/R5PjoYbTko https://t.co/eLiFJvyjpI
-
-
Mashup Score: 16Targeting FAK in anticancer combination therapies - 3 year(s) ago
Focal adhesion kinase (FAK) is overexpressed in many cancers and is involved in a multitude of oncogenic processes and resistance mechanisms. This Review discusses the rationale and preclinical evidence for FAK-based combination therapies and strategies for future development.
Source: Nature Reviews CancerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
NEW Review! #FocalAdhesionKinase (FAK) is involved in many oncogenic processes and #resistance mechanisms. JC Dawson Black, MC Frame @MargaretFrame11 et al discuss the preclinical evidence for FAK-based #CombinationTherapies. https://t.co/qLOacWnirp @EdinburghUni @CR_UK @EdinCRC https://t.co/igVDoOFS0F
-
š NEWS: ICR researchers studying mice identify a potential new drug combination for some #SkinCancer. Research into #CombinationTherapies will hopefully lead to more treatment options for #Cancer patients in the futureš https://t.co/91Z6sI1vJv #SkinCancerAwarenessMonth